SYSTEMS AND METHODS FOR DIAGNOSING AND TREATING CANCER

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

Agents for improved delivery of nucleic acids to eukaryotic cells

Interfering RNA molecules

Preventive or therapeutic agent for fibrosis

TARGETING DOMAIN AND RELATED SIGNAL ACTIVATED MOLECULAR DELIVERY

RNA amidates and thioamidates for RNAi

Adipocyte-targeting non-viral gene delivery system

Reduced size self-delivering RNAi compounds

NUCLEOTIDE SEQUENCE MOTIFS DIRECTING NUCLEIC ACID LOCATION TO EXTRACELLULAR VESICLES

Compounds and methods for trans-membrane delivery of molecules

Method for Inhibiting HIV Replication in Mammal and Human Cells

SHIP INHIBITION TO COMBAT OBESITY

Double-stranded ribonucleic acid as control against insects

Treatment of hyperhidrosis

METHOD OF SCREENING FOR CHAPERONIN MODULATOR

Autoimmune disease treatments

Methods and compositions for reducing immunosupression by tumor cells

QSOX1 AS AN ANTI-NEOPLASTIC DRUG TARGET

RESPIRATORY DISEASE-RELATED GENE SPECIFIC SIRNA, DOUBLE-HELICAL OLIGO RNA STRUCTURE CONTAINING SIRNA, COMPOSITON CONTAINING SAME FOR PREVENTING OR TREATING RESPIRATORY DISEASE

Replication factor C-40 (RFC40/RFC2) as a prognostic marker and target in estrogen positive and negative and triple negative breast cancer

COMPOSITIONS AND METHODS FOR MODULATION OF TARGET NUCLEIC ACIDS

Dosages and methods for delivering lipid formulated nucleic acid molecules

AGENTS FOR DOWNREGULATION OF THE ACTIVITY AND/OR AMOUNT OF BCL-XL AND/OR BCL-W

SiRNA targeting HSR1

PROTEIN INVOLVED IN DNA REPLICATION, AND MODULATION OF ITS ACTIVITY

COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES

Liposomes for modulating Wiskott-Aldrich syndrome protein

In vitro method of inhibiting the growth of radioresistant laryngeal cancer cells

Methods for identifying agents useful for modulating the expression and aggregation of CAG-expanded gene product in cells

cgb2 And cgb1 Genes; Diagnosis, Monitoring And Treatment Of Cancer

Modulation of NLGn4 expression, NK cell activity in non-alcoholic fatty liver disease (NAFLD)

Inhibition of MAP4K4 through RNAi

SILENCING OF POLO-LIKE KINASE EXPRESSION USING INTERFERING RNA

RNA interference in ocular indications

PROSTATE CANCER-SPECIFIC ALTERATIONS IN ERG GENE EXPRESSION AND DETECTION AND TREATMENT METHODS BASED ON THOSE ALTERATIONS

Methods and compositions for the treatment of cancer

Lipid encapsulating interfering RNA

Compositions and methods for inhibiting expression of the ALAS1 gene

Treatment of insulin resistance through inhibitors of transcription factor TSC22D4

Anti-sense oligonucleotides targeted against exon 9 of IL-23R-alpha gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases

Methods for treating inflammatory responses or diseases caused by inflammation using ApoA-I binding protein (APOA1BP)

Amine-containing lipidoids and uses thereof

Role of a cluster of long noncoding RNA transcripts in protecting the heart from pathological hypertrophy

MODULATORS OF ADP-DEPENDENT GLUCOKINASE (ADPGK) AND GLYCEROL-3-PHOSPHATE DEHYDROGENASE (GPD2) FOR THERAPY

Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

Compositions and methods for insecticidal control of stinkbugs

METHOD OF REGULATING CFTR EXPRESSION AND PROCESSING

Method for inhibiting HIV replication in mammal and human cells

Nucleic acid aptamers

Complement component C5 iRNA compositions and methods of use thereof

Single-Stranded Nucleic Acid Molecule for Controlling Gene Expression

Modulation of HSP47 expression

Inflammatory disease diagnosis and methods of treatment using lipopolysaccharides-responsive beige-like anchor

Therapeutics for the induction of endogenous steroidogenesis and methods associated with their identification

Compounds and methods for trans-membrane delivery of molecules

Lipids and lipid compositions for the delivery of active agents

Use of PKC-iota inhibitors for the treatment of breast cancer

Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same

CANCER EXAMINATION METHOD AND EXAMINATION KIT

DOUBLE STRANDED RNA COMPOUNDS TO RHOA AND USE THEREOF

Compositions and methods for inhibiting expression of the HAMP gene

Protection against ionizing radiation and chemotherapy toxicity via latexin regulation

IN VIVO PRODUCTION OF SMALL INTERFERING RNAS THAT MEDIATE GENE SILENCING

Method of isolating nucleic acid

Recurrent gene fusions in prostate cancer

Matriptase inhibitors and uses thereof against orthomyxoviridae infections

QSOX1 as an anti-neoplastic drug target

Use of hydrogen sulfide synthesis inhibitors for cancer therapy

Methods for diagnosis and treatment of amyotrophic lateral sclerosis based on an increased level of interaction between TDP-43 polypeptide and NF-KB P65 polypeptide

Composition and method for inner ear sensory hair cell regeneration and replacement

Lipid Formulated Compositions And Methods For Inhibiting Expression Of Transthyretin (TTR)

Modulators of itch ubiquitinase activity

METHODS AND USES INVOLVING GENETIC ABERRATIONS OF NAV3 AND ABERRANT EXPRESSION OF MULTIPLE GENES

Compositions and methods for treating cancer

NOVEL TREATMENT OF METABOLIC DISEASES

Synthetic lethality in cancer

Aptamer-RNAi therapeutic compositions

Phase changing formulations of nucleic acid payloads

Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells

Compositions and methods for the treatment of parkinson disease by the selective delivery of oligonucleotide molecules to specific neuron types

Prophylactic and/or therapeutic agent for inflammatory disease, and method for screening prophylactic and/or therapeutic drug for inflammatory disease

SiRNA TARGETING ETS1 AND ELK1 AND METHOD OF USING SAME IN THE INHIBITION OF CIP2A GENE IN CANCER TREATMENT

Methods and compositions for stimulating reepithelialisation during wound healing

METHODS, COMPOSITIONS AND KITS FOR PROMOTING MOTOR NEURON SURVIVAL AND TREATING AND DIAGNOSING NEURODEGENERATIVE DISORDERS

Small Interfering RNA Delivery

Foreign DNA surveillance protein

Therapeutic compositions

Nanoparticle mediated delivery of siRNA

RNA aptamers against BAFF-R as cell-type specific delivery agents and methods for their use

Compositions and methods for silencing marburg virus gene expression

RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA)

Phosphorous-linked oligomeric compounds and their use in gene modulation

siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis

A Novel EGFR Variant

NOVEL SINGLE CHEMICAL ENTITIES AND METHODS FOR DELIVERY OF OLIGONUCLEOTIDES

Hydrazinyl lipidoids and uses thereof

Methods of identifying compounds for the treatment of fibrosis by using S1PR5

Homeobox transcription factor ventx regulates differentiation and maturation of human dendritic cells

Compositions and methods for “resistance-proof” SiRNA therapeutics for influenza

RNAI MODULATION OF SCAP AND THERAPEUTIC USES THEREOF

Short interfering nucleic acid (siNA) molecules containing a 2′ internucleoside linkage

Polynucleotides and polypeptide sequences involved in the process of bone remodeling

GLUTAMATE DEHYDROGENASE IN IDH1- AND IDH2-MUTATED CANCERS

Composition for delivery of genetic material

Brush-poly (glycoamidoamine)-lipids and uses thereof

Fungal immunogens and related materials and methods

Hydrazinyl lipidoids and uses thereof

Method for treating breast cancer by targeting breast cancer stem cell

Composition comprising inhibitor against PAPSS2 gene or protein encoded by gene for inducing senescence in tumor cells and method for inducing senescence in tumor cells using the same

Down-regulating gene expression in insect pests

Huntington's disease therapeutic compounds

T-cell-specific humanized single fragment antibody delivery vehicle

Compositions and methods for reducing neointima formation

Lipopeptides for delivery of nucleic acids

MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF FIBROTIC DISEASES

Genetic amplification of IQGAP1 in cancer

RNAi-mediated inhibition of histamine receptor H1-related conditions

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Antiproliferative agent

Multi-targets interfering RNA molecules and their applications

Methods and compositions for the specific inhibition of beta-catenin by double-stranded RNA

Compositions comprising alternating 2′-modified nucleosides for use in gene modulation

Biocompatible infinite coordination polymer nanoparticle-nucleic acid conjugates for antisense gene regulation

Double stranded RNA constructs for aphid control

Composition for controlling stem cells pluripotency, containing LIN28A methylation inhibitor, and method for screening for LIN28A methylation inhibitor

Method for assaying microRNA, cancer therapeutic agent, and medicinal composition containing same for cancer therapy

Bruton's tyrosine kinase as anti-cancer drug target

Methods for preserving the viability of retinal ganglion cells in patients with glaucoma by an anti-TNF receptor 2 (anti-TNFR2) antibody

Compositions and methods for treating HIF-1α over-expressing cancers

METHOD OF TREATMENT OR PROPHYLAXIS INFTAMMATORY PAIN

METHODS AND COMPOSITIONS FOR IMPROVING SLEEP AND MEMORY

Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells

B7-H4 EXPRESSION ON TUMOR VASCULATURE

Viral and viral associated miRNAs and uses thereof

P-coumaroyl-CoA:monolignol transferase

Targeting chromatin modifiers for the treatment of medical conditions

Treatment of sex hormone binding globulin (SHBG) related diseases by inhibition of natural antisense transcript to SHBG

Small interference RNA for inhibiting intracellular expression of ribosomal protein S3

Biodegradable and clinically-compatible nanoparticles as drug delivery carriers

HSA-MIR-146B-5P-related nucleic acids and uses thereof

Signal activated RNA interference

Site-specific induction of bimolecular quadruplex-duplex hybrids and methods of using the same

Method for inhibiting proliferation of high LIX1L-expressing tumor cell, and tumor cell proliferation-inhibiting peptide

ApoIII and the Treatment and Diagnosis of Diabetes

METHOD FOR THE DIAGNOSIS, PROGNOSIS, AND TRATMENT OF CANCER METASTASIS

Mutations in DSTYK cause dominant urinary tract malformations

Long interfering nucleic acid duplexes targeting multiple RNA targets

Composition for treatment or metastasis suppression of cancers which includes p34 expression inhibitor or activity inhibitor as active ingredient

Oligonucleotides for modulating gene expression and uses thereof

In vivo delivery of oligonucleotides

siRNA-mediated gene silencing

FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITION FOR THE TREATMENT OF DISEASE

Biological Materials and Uses Thereof

Modified Poly(Beta-Amino Ester)s for Drug Delivery

Treatment of myocardial infarction by inhibiting the action of mAKAPβ

Use of GPR83 to identify pruritus-related substances

Biomarkers associated with BRM inhibition

Non-liposomal systems for nucleic acid delivery

Controlling fungal pathogens by disabling their small RNA pathways using RNAi-based strategy

Pharmaceutical composition comprising Nanog shRNA, and method of using Nanog shRNA to treat cancer

RNA sequence-specific mediators of RNA interference

ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES

Random RNAi libraries, methods of generating same, and screening methods utilizing same

STRAIN OF DEFORMED WING VIRUS (DWV)

Role for the perlman syndrome exonuclease Dis3l2 in the Lin28-let-7 pathway

METHODS AND PHARMACEUTICALS COMPOSITIONS FOR TREATING BREAST CANCERS

Methods for Promoting Reinnervation of Auditory Hair Cells

Treatment of staphylococcal disorders

Vectors for delivery of agents across biological membranes

Fatty acids and their use in conjugation to biomolecules

Therapeutic agent for fibroid lung

Methods of using ZSCAN4 for rejuvenating human cells

Methods and compositions related to T-cell activity

FALZ for use as a target for therapies to treat cancer

Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules

Treatment of LCAT gene related diseases by inhibition of a natural antisense transcript to LCAT

Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene

TREATING TH2-MEDIATED DISEASES BY INHIBITION OF BROMODOMAINS

miRNA BIOGENESIS IN EXOSOMES FOR DIAGNOSIS AND THERAPY

Compositions and methods for inhibition of expression of protein C (PROC) genes

Methods for increasing efficacy of lipid formulated siRNA

Treating hepatitis B virus infections by administering receptor associated protein (RAP)

Medicament for liver regeneration and for treatment of liver failure

Polypeptide based block copolymer and the process for the preparation thereof, and the polymer micelles using the same

Method for treating muscle-invasive bladder cancer, containing S100A9 and EGFR inhibitors and cisplatin as active ingredients

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF FACTOR VII GENE

PCSK9 iRNA compositions and methods of use thereof

Targeting microRNA miR-409-3P to treat prostate cancer

Serpinc1 iRNA compositions and methods of use thereof

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

CHIMERIC OLIGOMERIC COMPOUNDS AND THEIR USE IN GENE MODULATION

Method for expressing, secreting and transferring functional microRNAs/siRNAs and application thereof

Selective targeting of cancer stem cells

TIM RECEPTORS AS VIRUS ENTRY COFACTORS

PHF20 AND JMJD3 COMPOSITIONS AND METHODS OF USE IN CANCER IMMUNOTHERAPY

Lipid-Coated Albumin Nanoparticle Compositions and Methods of Making and Method of Using the Same

Method for enhancing a function of a T cell

Compositions and methods for reducing skin pigmentation

METHODS TO PREDICT AND PREVENT RESISTANCE TO TAXOID COMPOUNDS

Gene silencing of sugar-dependent 1 in

Organic compositions to treat EPAS1-related diseases

Method for inhibiting tumor growth through RNA-interference using liposomally associated CDC20 siRNA

Method for treating and/or preventing myopia

Methods of preserving and protecting pancreatic beta cells and treating or preventing diabetes by inhibiting NOX-1

Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent

Therapeutic and diagnostic methods relating to cancer stem cells

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER

METHODS FOR REGULATING HAIR GROWTH DISORDERS

Rspondins as modulators of angiogenesis and vasculogenesis

Biodegradable lipids for the delivery of active agents

Method of altering vascular permeability and uses thereof

Methods of treating cancer

Tetrary gene delivery system for gene therapy and methods of its use

BIOMARKERS FOR THE PREDICTION OF PRETERM BIRTH

MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF DISEASES ASSOCIATED WITH EPITHELIAL MESENCHYMAL TRANSITION

Methods for co-silencing expression of genes in filamentous fungal strains and uses thereof

Compositions And Methods To Enhance Protein Expression

Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability

RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions

Diagnostic and treatment for chronic and acute phase myeloid leukemia

METHODS AND COMPOSITIONS FOR MANAGING VASCULAR CONDITIONS

TOX INHIBITION FOR THE TREATMENT OF CANCER

Notch inhibition in the prevention of vein graft failure

Nanoparticles stabilized with nitrophenylboronic acid compositions

Method and compositions for the genetic control of insect pests in cotton plants by chitin synthase gene silencing

Methods of diagnosing, treating and monitoring diabetic retinopathy

Methods to identify and treat subjects having corticosteroid-resistant asthma

Modified oligonucleotides for telomerase inhibition

Antisense oligonucleotides directed against connective tissue growth factor and uses thereof

Influenza-activated constructs and methods of use thereof

MODIFIED SMALL INTERFERING RNA MOLECULES AND METHODS OF USE

CCCTC-Binding Factor (CTCF) RNA Interactome

Oligonucleotide

Treatment of metastatic tumors

Composition for gene delivery comprising chitosan and liquid crystal formation material

Process for formulating an anionic agent

Lipid formulations for delivery of therapeutic agents to solid tumors

Inhibitors of Branched-Chain-Aminotransferase-1 (BCAT1) for the Treatment of Brain Tumors

Methods and compositions relating to the treatment of cancer

STABLE TRANSFORMATION OF A POPULATION AND A METHOD OF BIOCONTAINMENT USING HAPLOINSUFFICIENCY AND UNDERDOMINANCE PRINCIPLES

Furin-knockdown bi-functional RNA

USE OF VEGFR1 AS A BIOMARKER

Genetic control method and compositions against insect pests in cotton plants by the silencing of genes of the laccase family

COMPOSITIONS AND METHODS OF INHIBITING GENE EXPRESSION IN A LUNG

Compositions and methods for treating pancreatic cancer

Cell-type specific aptamer-siRNA delivery system for HIV-1 therapy

Methods to screen compounds for regulating USF1 activity and methods and compounds to treat cardiometabolic and lipid pathologies

ShRNA molecules and methods of use thereof

Intranuclear protein transduction through a nucleoside salvage pathway

Positively charged polysaccharides for RNA transfection

Suppression of malignant mesothelioma by overexpression or stimulation of endothelial protein C receptors (EPCR)

Methods of treating cholangiocarcinoma

PLATELETS TRANSFECTED BY EXOGENOUS GENETIC MATERIAL AND PLATELET MICROPARTICLES OBTAINED BY SAID TRANSFECTED PLATELETS, METHOD FOR THE PREPARATION AND USES THEREOF

Low molecular weight cyclic amine containing cationic lipids for oligonucleotide delivery

Inhibitors of miRNAs 221 and 222 for anti-tumor activity in multiple myeloma

MODIFIED SMALL INTERFERING RNA MOLECULES AND METHODS OF USE

Methods for treating eye disorders

Methods and compositions for targeting immunoglobulins

Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin

Method of producing dicer

T cell balance gene expression, compositions of matters and methods of use thereof

METHODS OF MODULATING DLK STABILITY

INHIBITION OF THE COMPLEMENT SYSTEM

Methods of modulating GABAergic inhibitory synapse formation and function

Cancer antigen EEF2

Lipids, lipid complexes and use thereof

Technology for the Preparation of Microparticles

Modulators of the interaction of astrin and raptor, and uses thereof in cancer therapy

Transcription factor which regulates flavonoid, phenylpropanoid, tyrosine, and tryptophan pathways

Compositions and methods for inhibiting expression of a target gene

ANTIGENE OLIGOMERS INHIBIT TRANSCRIPTION

MELK regulation for the treatment of breast cancer

Lipid Formulated Compositions and Methods for Inhibiting Expression of a Gene from the Ebola Virus

Methods of treating a metabolic syndrome by modulating heat shock protein (HSP) 90-beta

Methods of inhibiting proliferation of estrogen-independent cancer cells

Peptide-based in vivo siRNA delivery system

Plants as functional microRNA and/or functional siRNA carriers, preparation methods and uses thereof

Polyvalent RNA-nanoparticle compositions

METHOD OF TREATING DELAYED HEALING OF A WOUND ASSOCIATED WITH DIABETES

Methods and compositions involving miRNA and miRNA inhibitor molecules

Method for diagnosis, prognosis and determination of treatment for cutaneous T-cell lymphoma

DIAGNOSTIC MARKERS FOR TREATING CELL PROLIFERATIVE DISORDERS WITH TELOMERASE INHIBITORS

METHODS FOR CONTROLLING STEM CELL DIFFERENTIATION

Reduction of TGF beta signaling in myeloid cells in the treatment of cancer

Methods and compositions for inducing deregulation of EPHA7 and ERK phosphorylation in human acute leukemias

USP30 INHIBITORS AND METHODS OF USE

siRNA FOR INHIBITION OF USP15 EXPRESSION AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME

RNAi-related inhibition of TNF-alpha signaling pathway for treatment of ocular angiogenesis

HBV treatment

Compositions and methods to promote bone formation

Methods and compositions involving miRNA and miRNA inhibitor molecules

Methods of trans-differentiating a terminally differentiated target cell to a neuron

Targeted sensitization of non-del(5q) malignant cells

Cationic lipid

FURTHER USE OF PROTEIN KINASE N BETA

Polypeptides Having Cellulolytic Enhancing Activity And Polynucleotides Encoding Same

Methods and compositions to modulate RNA processing

RNA TARGETED TO C-MET